Feed AFIB
AF

Acutus Medical, Inc. AFIB OTC · Healthcare · United States

$0.00 +0.00% +$0.00

Market cap
$2.99K
Enterprise value
$21.7M
P/E
-
Forward P/E
-
PEG
-
P/S
0.0x
P/FCF
-
EV/EBITDA
9.7x
ROIC
-0.5%
Gross margin
5.0%
Net margin
-47.4%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
9.7x
Beta
6.03
Free float
67.3%

About the company

Acutus Medical, Inc. is an American company focused on the development and manufacturing of advanced technologies for the treatment of cardiac arrhythmias. The company specializes in innovative technologies and imaging systems that enable physicians to better diagnose and treat cardiac arrhythmias. Their products include electrophysiological cardiac stimulation catheters and imaging systems that allow for precise mapping and navigation during procedures related to cardiac arrhythmias. Acutus Medical is known for its innovative approaches and technological innovations that help physicians provide treatment with high efficacy and safety for patients. Acutus Medical, Inc. shares could be an interesting choice for investors looking for opportunities in the treatment of cardiac diseases and healthcare technologies.

Sector

Healthcare

Industry

Medical - Devices

CEO

Takeo Mukai

Employees

85

Headquarters

Carlsbad

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: Operating profit does not even cover the interest on its debt.
  • What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy